Euglycemic Clamp Dose-response Study Comparing a New Insulin Glargine Formulation With Lantus®

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
Primary Objective: - To assess the total metabolic effect ratios of a new insulin glargine formulation versus Lantus® Secondary Objectives: * To assess the exposure ratios of a new insulin glargine formulation versus Lantus® * To compare the duration of action of a new insulin glargine formulation versus Lantus® * To explore the dose response and dose exposure relationship of a new insulin glargine formulation * To assess the safety and tolerability of a new insulin glargine formulation
Epistemonikos ID: b324a8e840daa3fcf395b68a687065ee0dde50c4
First added on: May 05, 2024